2013
DOI: 10.5606/tgkdc.dergisi.2013.7813
|View full text |Cite
|
Sign up to set email alerts
|

Dexmedetomidine combined with narcotic anesthesia induction in coronary artery bypass graft surgery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 24 publications
0
3
0
Order By: Relevance
“…[10,14] Although they are short-termed, myocardial oxygen demand may increase and may lead to myocardial ischemia in patients with coronary artery disease. [15] To prevent Rate pressure product…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…[10,14] Although they are short-termed, myocardial oxygen demand may increase and may lead to myocardial ischemia in patients with coronary artery disease. [15] To prevent Rate pressure product…”
Section: Discussionmentioning
confidence: 99%
“…[3,4,15,16] Lidocaine is an amid-type local anesthetic which is also classified as class IB antiarrhythmic drug, as it has antagonistic action on voltage-gated sodium channels. Lidocaine also inhibits N-methyl-D-aspartate (NMDA) receptors.…”
Section: Macintoshmentioning
confidence: 99%
“…Dexmedetomidine (DEX) is a novel type of highly selective α2-adrenergic receptor agonist and has been used as a sedative or adjuvant anesthetic drug to maintain more stable hemodynamic parameters for patients undergoing cardiac surgery. 5 The original application for DEX was the short-term sedation for adult patients in the intensive care unit (ICU) who were receiving invasive mechanical ventilation. Then DEX received approval for monitored anesthesia care in adults in 2008.…”
Section: Introductionmentioning
confidence: 99%